Cover Image

Serum Adipokine and Ghrelin Levels in Nonalcoholic Steatohepatitis

Adipokines and ghrelin play role in insulin resistance, the key pathophysiological abnormality in patients with nonalcoholic fatty liver diseases. In the present study, relationship between nonalcoholic steatohepatitis (NASH) and serum adipokine and ghrelin levels was investigated. Thirty seven pati...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mehmet Yalniz (Author), Ibrahim Halil Bahcecioglu (Author), Huseyin Ataseven (Author), Bilal Ustundag (Author), Fulya Ilhan (Author), Orhan K. Poyrazoglu (Author), Ahmet Erensoy (Author)
Format:	Book
Published:	Hindawi Limited, 2006-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Levels of Ghrelin, Leptin, TNF-α, and IL-6 in Liver Cirrhosis and Hepatocellular Carcinoma due to HBV and HDV Infection
by: Huseyin Ataseven, et al.
Published: (2006)

Adipokines in Nonalcoholic Steatohepatitis: From Pathogenesis to Implications in Diagnosis and Therapy
by: Emmanuel A. Tsochatzis, et al.
Published: (2009)

Oligonucleotide therapies for nonalcoholic steatohepatitis
by: Sixu Li, et al.
Published: (2024)

The role of adipokines and ghrelin in interactions and clinical implications in childhood obesity
by: Karrar Haider Haddawi, et al.
Published: (2024)

Semaglutide in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
by: Magdalena Mazurek, et al.
Published: (2023)

Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism
by: Yifei Lu, et al.
Published: (2022)

Bardet-Biedl syndrome with nonalcoholic steatohepatitis, hypertension, and hypothyroidism
by: Yatendra Singh, et al.
Published: (2016)

Correction: Medaka as a model for human nonalcoholic steatohepatitis
by: Toshihiko Matsumoto, et al.
Published: (2023)

Ductular reaction in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study)
by: O. M. Gavrilyuk
Published: (2014)

Studying the serum ghrelin levels of the elite athletes and sedentary controls fasting at the time of Ramadan
by: C. Berkan Alpay, et al.
Published: (2014)

Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options
by: Milic S, et al.
Published: (2015)

Psoralea corylifolia L. Attenuates Nonalcoholic Steatohepatitis in Juvenile Mouse
by: Lishan Zhou, et al.
Published: (2017)

Triglyceride peroxidation progression in lipid droplets of hepatocytes in nonalcoholic steatohepatitis
by: Kota Saito, et al.
Published: (2024)

Ferroptosis plays a novel role in nonalcoholic steatohepatitis pathogenesis
by: Fei Xiong, et al.
Published: (2022)

Dapagliflozin protects against nonalcoholic steatohepatitis in db/db mice
by: Panshuang Qiao, et al.
Published: (2022)

Taurine and tea polyphenols combination ameliorate nonalcoholic steatohepatitis in rats
by: Wenhua Zhu, et al.
Published: (2017)

Schisandra lignans ameliorate nonalcoholic steatohepatitis by regulating aberrant metabolism of phosphatidylethanolamines
by: Lijuan Xue, et al.
Published: (2023)

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis
by: Mazo DF, et al.
Published: (2013)

Altered cisplatin pharmacokinetics during nonalcoholic steatohepatitis contributes to reduced nephrotoxicity
by: Joseph L. Jilek, et al.
Published: (2021)

LUBAC Formation Is Impaired in the Livers of Mice with MCD-Dependent Nonalcoholic Steatohepatitis
by: Yasuka Matsunaga, et al.
Published: (2015)

The therapeutic potential of C-C chemokine receptor antagonists in nonalcoholic steatohepatitis
by: Michael Doulberis, et al.
Published: (2020)

Sesamin ameliorates nonalcoholic steatohepatitis through inhibiting hepatocyte pyroptosis in vivo and in vitro
by: Teng Zhang, et al.
Published: (2024)

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum]
by: Mazo DF, et al.
Published: (2013)

Comment on "Metabolic Changes and Serum Ghrelin Level in Patients with Psoriasis"
by: Mehmet Agilli, et al.
Published: (2015)

Serum levels of ghrelin, adipokines, and tumor necrosis factor-α (TNF-α) in patients with juvenile idiopathic arthritis in Assuit University Hospitals: Relation to nutritional status and disease activity
by: Zahraa I. Selim, et al.
Published: (2015)

Protective Role of Genistein in Acute Liver Damage Induced by Carbon Tetrachloride
by: Nalan Kuzu, et al.
Published: (2007)

Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis
by: James Twiss, et al.
Published: (2023)

Nonalcoholic Steatohepatitis (NASH) and Atherosclerosis: Explaining Their Pathophysiology, Association and the Role of Incretin-Based Drugs
by: Eleftheria Galatou, et al.
Published: (2022)

Hepatic COX1 loss leads to impaired autophagic flux and exacerbates nonalcoholic steatohepatitis
by: Qian Yu, et al.
Published: (2023)

An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis
by: M. Imawari, et al.
Published: (2023)

Host ALDH2 deficiency aggravates nonalcoholic steatohepatitis through gut-liver axis
by: Zhan-Ming Li, et al.
Published: (2023)

Human Liver-Derived Stem Cells Improve Fibrosis and Inflammation Associated with Nonalcoholic Steatohepatitis
by: Stefania Bruno, et al.
Published: (2019)

Nonalcoholic steatohepatitis and obesity as one of the main predictors of metabolic syndrome development in children and adolescents
by: O.Yu. Belousova
Published: (2017)

Clinical and pathogenetic differences of the course of flow nonalcoholic steatohepatitis in obese patients with and without hypertension
by: O.S. Khukhlina, et al.
Published: (2013)

Immunohistochemistry pattern of hepatic inflammatory and insulin resistance markers in experimental model of nonalcoholic steatohepatitis
by: Mônica Souza de Miranda Henriques, et al.
Published: (2014)

Serum concentrations of adipokines in psoriasis and cardiometabolic risk
by: Anna Pasierb, et al.
Published: (2019)

Costs associated with nonalcoholic steatohepatitis disease progression in Medicare patients: a retrospective cohort study
by: Yestle Kim, et al.
Published: (2024)

G protein-coupled receptor 35 attenuates nonalcoholic steatohepatitis by reprogramming cholesterol homeostasis in hepatocytes
by: Xiaoli Wei, et al.
Published: (2023)

Anti-Autophagy Mechanism of Zhi Gan Prescription Based on Network Pharmacology in Nonalcoholic Steatohepatitis Rats
by: Chufeng Qin, et al.
Published: (2021)

Health-related quality of life burden of nonalcoholic steatohepatitis: a robust pragmatic literature review
by: Tessa Kennedy-Martin, et al.
Published: (2018)